Advisors Asset Management Inc. Acquires 4,647 Shares of DaVita Inc. (NYSE:DVA)

Advisors Asset Management Inc. boosted its holdings in DaVita Inc. (NYSE:DVA) by 34.3% in the third quarter, Holdings Channel reports. The firm owned 18,201 shares of the company’s stock after purchasing an additional 4,647 shares during the quarter. Advisors Asset Management Inc.’s holdings in DaVita were worth $2,984,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. Transcendent Capital Group LLC bought a new stake in shares of DaVita during the 3rd quarter worth approximately $25,000. Blue Trust Inc. grew its stake in shares of DaVita by 58.6% in the second quarter. Blue Trust Inc. now owns 211 shares of the company’s stock valued at $29,000 after buying an additional 78 shares in the last quarter. Family Firm Inc. acquired a new position in DaVita during the second quarter worth $43,000. Versant Capital Management Inc raised its position in DaVita by 90.6% during the second quarter. Versant Capital Management Inc now owns 326 shares of the company’s stock worth $45,000 after acquiring an additional 155 shares in the last quarter. Finally, Friedenthal Financial acquired a new stake in DaVita in the second quarter valued at $48,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on DVA. Barclays boosted their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial upped their price objective on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Bank of America lifted their target price on DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 7th. Finally, UBS Group raised their price target on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $161.80.

DaVita Price Performance

DaVita stock opened at $165.51 on Friday. The company has a market capitalization of $13.57 billion, a price-to-earnings ratio of 17.85, a PEG ratio of 0.93 and a beta of 0.89. The stock’s 50 day moving average is $158.31 and its 200-day moving average is $148.36. The company has a current ratio of 1.37, a quick ratio of 1.33 and a debt-to-equity ratio of 15.78. DaVita Inc. has a 12 month low of $98.26 and a 12 month high of $168.50.

DaVita (NYSE:DVA) last posted its earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a return on equity of 88.18% and a net margin of 6.53%. The firm had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the business posted $2.85 EPS. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. Equities research analysts expect that DaVita Inc. will post 9.71 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Joel Ackerman sold 64,029 shares of the stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $155.06, for a total transaction of $9,928,336.74. Following the sale, the chief financial officer now owns 111,481 shares in the company, valued at approximately $17,286,243.86. This trade represents a 36.48 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Javier Rodriguez sold 50,000 shares of DaVita stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $165.05, for a total transaction of $8,252,500.00. Following the completion of the transaction, the chief executive officer now directly owns 837,835 shares in the company, valued at $138,284,666.75. This trade represents a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 156,086 shares of company stock worth $24,807,161 in the last 90 days. Company insiders own 2.00% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.